Category: EN

evian®, Michelin-Starred Chef and Restaurateur Daniel Boulud, and Tennis Ambassador Frances Tiafoe Serve Up First-Ever Culinary Collaboration in Celebration of New York’s Largest Tennis Tournament

The limited-edition experience – available in New York and nationwide – spotlights evian’s role in rejuvenating the body and mind both courtside and at the table evian®, Chef Daniel Boulud and tennis ambassador Frances Tiafoe debut their first-ever culinary collaboration in celebration of New York’s largest tennis tournament, merging fine dining with the refreshing taste of evian. The […]

Cystoscopy and Ureteroscopy Market is Growing at 6.9% CAGR to Reach US$729.30 million by 2031; Due to Increasing Prevalence of Urological Diseases | The Insight Partners

SAN FRANCISCO, Aug. 21, 2025 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, the cystoscopy and ureteroscopy market is observing significant growth owing to the increasing prevalence of urological disease and expansion in emerging economies. The cystoscopy and ureteroscopy market is expected to reach US$729.30 million by 2031 from US$459.11 million in […]

First National Realty Partners Projects Steady Retail Real Estate Performance Through Late 2025

Grocery-Anchored and Necessity-Based Properties Set to Lead Sector Growth Amid Robust Demand and Limited Supply RED BANK, N.J., Aug. 21, 2025 /PRNewswire/ — First National Realty Partners (FNRP), a leading national private equity commercial real estate firm, anticipates retail real estate fundamentals to remain relatively strong through the remainder of 2025, driven by sustained demand for […]

LeveL Markets Announces Trading Connectivity Partnership with Nasdaq Canada

Luminex® to Enable Clients to Access Nasdaq Canada and Canadian Market Liquidity BOSTON, Aug. 21, 2025 /PRNewswire/ — LeveL Markets, LLC, a U.S. registered broker-dealer and the operator of the LeveL and the Luminex Alternative Trading Systems, and Nasdaq Canada, today announced a connectivity partnership that will provide customers on the Luminex ATS with access to […]

Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia

-Dabogratinib is the only oral FGFR3-selective inhibitor in clinical development for achondroplasia- -Initial results from safety sentinel cohort expected in 2H 2026- CARLSBAD, Calif., Aug. 21, 2025 /PRNewswire/ — Tyra Biosciences, Inc. (Nasdaq: TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, […]

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

At all doses and formulations evaluated in Part 1 of the trial, Z-1018 was well-tolerated and demonstrated a favorable tolerability profile, including lower solicited local and systemic post-injection reactions, versus Shingrix Z-1018 demonstrated robust immune responses in all dose arms, including a 100% humoral vaccine response rate at the dose selected for advancement, with comparable […]

PTC Therapeutics to Participate at Upcoming Investor Conferences

WARREN, N.J., Aug. 21, 2025 /PRNewswire/ — PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that its executives will speak at the following conferences: Cantor Global Healthcare Conference 2025Wednesday, Sept. 3 at 8:35 a.m. ET Wells Fargo 2025 Healthcare ConferenceThursday, Sept. 4 at 11:00 a.m. ET Morgan Stanley 23rd Annual Global Healthcare ConferenceMonday, Sept. 8 at 9:15 […]